Published Mr. Natchanon Sathapanapitagkit, Pharm.D., a pharmacist from the Sterile Production Unit, Pharmacy Department at Siriraj Hospital, Mahidol University, participated in the “Asia Pacific Oncology Pharmacy Congress (APOPC) 2024” in Tokyo, Japan, on October 12th – 13th, 2024. He presented his research through a poster titled “Oncologic Outcomes of a Modified Desensitization Protocol for Paclitaxel and Carboplatin in Gynecologic Oncology Patients”. Pharmacist Sathapanapitagkit shared Siriraj’s innovative findings with international colleagues and sought new insights to further improve cancer care at Siriraj Hospital.
The APOPC 2024, themed “Unite Asian Oncology Pharmacists: Start and Develop Next Generations”, focused on recent advancements, the integration of AI and digital transformation (DX) in oncology pharmacy, and fostering collaborative networks among oncology pharmacists across the Asia-Pacific region.
